Tasken K, Aandahl EM. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev. 2004;84:137–67.
Article
CAS
PubMed
Google Scholar
Kumar N, Goldminz AM, Kim N, Gottlieb AB. Phosphodiesterase 4-targeted treatments for autoimmune diseases. BMC Med. 2013;11:96.
Article
PubMed Central
CAS
PubMed
Google Scholar
Henney CS, Lichtenstein LM. The role of cyclic AMP in the cytolytic activity of lymphocytes. J Immunol. 1971;107:610–2.
CAS
PubMed
Google Scholar
Jin SL, Ding SL, Lin SC. Phosphodiesterase 4 and its inhibitors in inflammatory diseases. Chang Gung Med J. 2012;35:197–210.
PubMed
Google Scholar
Essayan DM. Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochem Pharmacol. 1999;57:965–73.
Article
CAS
PubMed
Google Scholar
Giembycz MA, Corrigan CJ, Seybold J, Newton R, Barnes PJ. Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br J Pharmacol. 1996;118:1945–58.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hidi R, Timmermans S, Liu E, Schudt C, Dent G, Holgate ST, et al. Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis. Eur Respir J. 2000;15:342–9.
Article
CAS
PubMed
Google Scholar
Manning CD, Burman M, Christensen SB, Cieslinski LB, Essayan DM, Grous M, et al. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B. Br J Pharmacol. 1999;128:1393–8.
Article
PubMed Central
CAS
PubMed
Google Scholar
Spina D. PDE4 inhibitors: current status. Br J Pharmacol. 2008;155:308–15.
Article
PubMed Central
CAS
PubMed
Google Scholar
Giembycz MA. Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? Drugs. 2000;59:193–212.
Article
CAS
PubMed
Google Scholar
Dyke HJ, Montana JG. Update on the therapeutic potential of PDE4 inhibitors. Expert Opin Investig Drugs. 2002;11:1–13.
Article
CAS
PubMed
Google Scholar
Dietsch GN, Dipalma CR, Eyre RJ, Pham TQ, Poole KM, Pefaur NB, et al. Characterization of the inflammatory response to a highly selective PDE4 inhibitor in the rat and the identification of biomarkers that correlate with toxicity. Toxicol Pathol. 2006;34:39–51.
Article
CAS
PubMed
Google Scholar
Niu M, Dong F, Tang S, Fida G, Qin J, Qiu J, et al. Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors. PLoS One. 2013;8:e82360.
Article
PubMed Central
PubMed
Google Scholar
Man HW, Schafer P, Wong LM, Patterson RT, Corral LG, Raymon H, et al. Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihy dro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor. J Med Chem. 2009;52:1522–4.
Article
CAS
PubMed
Google Scholar
Schafer PH, Parton A, Capone L, Cedzik D, Brady H, Evans JF, et al. Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cell Signal. 2014;26:2016–29.
Article
CAS
PubMed
Google Scholar
Schafer PH, Parton A, Gandhi AK, Capone L, Adams M, Wu L, et al. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. Br J Pharmacol. 2010;159:842–55.
Article
PubMed Central
CAS
PubMed
Google Scholar
Montesinos MC, Takedachi M, Thompson LF, Wilder TF, Fernandez P, Cronstein BN. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: Findings in a study of ecto-5'-nucleotidase gene-deficient mice. Arthritis Rheum. 2007;56:1440–5.
Article
CAS
PubMed
Google Scholar
Momtazi M, Kwan P, Ding J, Anderson CC, Honardoust D, Goekjian S, et al. A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar. Wound Repair Regen. 2013;21:77–87.
Article
PubMed
Google Scholar
Mediero A, Perez-Aso M, Cronstein BN. Activation of EPAC1/2 is essential for osteoclast formation by modulating NFkappaB nuclear translocation and actin cytoskeleton rearrangements. FASEB J. 2014;28:4901–13.
Article
CAS
PubMed
Google Scholar
McCann FE, Palfreeman AC, Andrews M, Perocheau DP, Inglis JJ, Schafer P, et al. Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis. Arthritis Res Ther. 2010;12:R107.
Article
PubMed Central
PubMed
Google Scholar
Hasko G, Cronstein B. Regulation of inflammation by adenosine. Front Immunol. 2013;4:85.
Article
PubMed Central
PubMed
Google Scholar
Pessler F, Mayer CT, Jung SM, Behrens EM, Dai L, Menetski JP, et al. Identification of novel monosodium urate crystal regulated mRNAs by transcript profiling of dissected murine air pouch membranes. Arthritis Res Ther. 2008;10:R64.
Article
PubMed Central
PubMed
Google Scholar
Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. J Immunol. 2010;185:6413–9.
Article
CAS
PubMed
Google Scholar
Schett G, Sloan VS, Stevens RM, Schafer P. Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases. Ther Adv Musculoskelet Dis. 2010;2:271–8.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nemeth ZH, Lutz CS, Csoka B, Deitch EA, Leibovich SJ, Gause WC, et al. Adenosine Augments IL-10 Production by Macrophages through an A2B Receptor-Mediated Posttranscriptional Mechanism. J Immunol. 2005;175:8260–70.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hasko G, Pacher P, Deitch EA, Vizi ES. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther. 2007;113:264–75.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kara FM, Chitu V, Sloane J, Axelrod M, Fredholm BB, Stanley ER, et al. Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function. FASEB J. 2010;24:2325–33.
Article
PubMed Central
CAS
PubMed
Google Scholar
Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, Boons GJ, et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol. 2003;163:711–21.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cronstein BN, Eberle MA, Gruber HE, Levin RI. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A. 1991;88:2441–5.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cheng X, Ji Z, Tsalkova T, Mei F. Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin. 2008;40:651–62.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cooper DM, Tabbasum VG. Adenylate cyclase-centred microdomains. Biochem J. 2014;462:199–213.
Article
CAS
PubMed
Google Scholar
Perez-Aso M, Mediero A, Cronstein BN. Adenosine A2A receptor (A2AR) is a fine-tune regulator of the collagen1:collagen3 balance. Purinergic signalling. 2013;9:573–83.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gottlieb AB, Strober B, Krueger JG, Rohane P, Zeldis JB, Hu CC, et al. An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast. Curr Med Res Opin. 2008;24:1529–38.
Article
CAS
PubMed
Google Scholar
Tokuda H, Hirade K, Wang X, Oiso Y, Kozawa O. Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts. J Endocrinol. 2003;177:101–7.
Article
CAS
PubMed
Google Scholar
Muller GW, Shire MG, Wong LM, Corral LG, Patterson RT, Chen Y, et al. Thalidomide analogs and PDE4 inhibition. Bioorg Med Chem Lett. 1998;8:2669–74.
Article
CAS
PubMed
Google Scholar
Borchers AT, Keen CL, Cheema GS, Gershwin ME. The use of methotrexate in rheumatoid arthritis. Semin Arthritis Rheum. 2004;34:465–83.
Article
CAS
PubMed
Google Scholar
Schulte G, Fredholm BB. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal. 2003;15:813–27.
Article
CAS
PubMed
Google Scholar
Barrera P, Haagsma CJ, Boerbooms AM, Van Riel PL, Borm GF, Van de Putte LB, et al. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis. Br J Rheumatol. 1995;34:747–55.
Article
CAS
PubMed
Google Scholar
Spadaro A, Taccari E, Riccieri V, Sensi F, Sili Scavalli A, Zoppini A. Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis. Rev Rhum Engl Ed. 1997;64:89–94.
CAS
PubMed
Google Scholar
Gerards AH, de Lathouder S, de Groot ER, Dijkmans BA, Aarden LA. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. Rheumatology. 2003;42:1189–96.
Article
CAS
PubMed
Google Scholar
Sung JY, Hong JH, Kang HS, Choi I, Lim SD, Lee JK, et al. Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis. Immunopharmacology. 2000;47:35–44.
Article
CAS
PubMed
Google Scholar
Olsen NJ, Spurlock 3rd CF, Aune TM. Methotrexate induces production of IL-1 and IL-6 in the monocytic cell line U937. Arthritis Res Ther. 2014;16:R17.
Article
PubMed Central
PubMed
Google Scholar
Schafer P, Chen P, Fang L, Wang A, Chopra R: Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis: pharmacodynamic results of a phase 3, randomized controlled trial. Annual European Congress of Rheumatology 2014:SAT0402.
Rich TC, Xin W, Mehats C, Hassell KA, Piggott LA, Le X, et al. Cellular mechanisms underlying prostaglandin-induced transient cAMP signals near the plasma membrane of HEK-293 cells. Am J Physiol Cell Physiol. 2007;292:C319–31.
Article
CAS
PubMed
Google Scholar
McConnachie G, Langeberg LK, Scott JD. AKAP signaling complexes: getting to the heart of the matter. Trends Mol Med. 2006;12:317–23.
Article
CAS
PubMed
Google Scholar
Zaccolo M, Movsesian MA. cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res. 2007;100:1569–78.
Article
CAS
PubMed
Google Scholar
Fischmeister R, Castro LR, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J, et al. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res. 2006;99:816–28.
Article
CAS
PubMed
Google Scholar
Georg S, Hu A, Stevens R. Oral Apremilast Is Effective with and without Concomitant Methotrexate Therapy in the Treatment of Subjects with Active Psoriatic Arthritis [abstract]. Arthritis Rheum. 2011;63:10.
Google Scholar
Kavanaugh A, Mease PJ, Gomez-Reino JJ, Adebajo AO, Wollenhaupt J, Gladman DD, et al. Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor. Ann Rheum Dis. 2014;73:1020–6.
Article
PubMed Central
CAS
PubMed
Google Scholar
Eigler A, Siegmund B, Emmerich U, Baumann KH, Hartmann G, Endres S. Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J Leukoc Biol. 1998;63:101–7.
CAS
PubMed
Google Scholar
de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 1998;396:474–7.
Article
PubMed
Google Scholar
Bryn T, Mahic M, Enserink JM, Schwede F, Aandahl EM, Tasken K. The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages. J Immunol. 2006;176:7361–70.
Article
CAS
PubMed
Google Scholar
Hertz AL, Bender AT, Smith KC, Gilchrist M, Amieux PS, Aderem A, et al. Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages. Proc Natl Acad Sci U S A. 2009;106:21978–83.
Article
PubMed Central
CAS
PubMed
Google Scholar